| Activity—all admissions for biliary disease | % Procedures within 8 days (all admissions) | Relative change from baseline | Combined model (adjusted for control group) | ||||
---|---|---|---|---|---|---|---|---|
Baseline | Intervention | Baseline (%) | Intervention (%) | Relative change | 95% confidence interval | Relative change | 95% confidence interval | |
All Chole-QuIC | 13,929 | 7944 | 9.4 | 14.6 | 1.56* | 1.38 to 1.75 | 1.45* | 1.29 to 1.62 |
Control | 147,495 | 83,391 | 14.2 | 15.3 | 1.08* | 1.02 to 1.14 | Â | Â |
Site 1 | 521 | 301 | 8.8 | 25.9 | 2.94* | 2.02 to 4.27 | 2.73* | 1.88 to 3.96 |
Site 2 | 964 | 521 | 12.2 | 26.5 | 2.16* | 1.69 to 2.77 | 2.01* | 1.55 to 2.60 |
Site 3 | 513 | 355 | 16.8 | 35.2 | 2.10* | 1.60 to 2.76 | 1.95* | 1.47 to 2.59 |
Site 4 | 1103 | 629 | 9.9 | 20.8 | 2.09* | 1.45 to 3.01 | 1.96* | 1.50 to 2.55 |
Site 5 | 1333 | 770 | 4.6 | 8.6 | 1.88* | 1.27 to 2.77 | 1.74* | 1.22 to 2.49 |
Site 6 | 1114 | 619 | 8.5 | 14.7 | 1.72* | 1.06 to 2.79 | 1.60* | 1.19 to 2.16 |
Site 7 | 1189 | 627 | 6.7 | 11.2 | 1.68* | 1.06 to 2.65 | 1.54* | 1.11 to 2.15 |
Site 8 | 1413 | 900 | 14.4 | 19.6 | 1.35* | 1.11 to 1.66 | 1.26* | 1.01 to 1.56 |
Site 9 | 1213 | 684 | 6.5 | 8.3 | 1.28 | 0.88 to 1.85 | 1.19 | 0.84 to 1.68 |
Site 10 | 1476 | 760 | 8.4 | 8.8 | 1.03 | 0.64 to 1.66 | 0.97 | 0.72 to 1.33 |
Site 11 | 1505 | 793 | 2.9 | 3.0 | 1.02 | 0.59 to 1.77 | 0.96 | 0.58 to 1.59 |
Site 12 | 1585 | 985 | 16.5 | 14.2 | 0.86 | 0.69 to 1.09 | 0.8 | 0.64 to 100 |